{"DataElement":{"publicId":"5508106","version":"1","preferredName":"Fluorescence In Situ Hybridization Philadelphia Chromosome Positive Finding Metaphase Process Laboratory Procedure Outcome Percentage 0 Decimal Place Value","preferredDefinition":"The 0 decimal place numeric laboratory value measured, assigned or computed related to the assessment of philadelphia chromosome positive metaphases found via fluorescence in situ hybridization.","longName":"5508097v1.0:3061015v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"5508097","version":"1","preferredName":"Fluorescence In Situ Hybridization Philadelphia Chromosome Positive Finding Metaphase Process","preferredDefinition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping._A translocation between chromosomes 9 and 22. It is the hallmark for chronic myelogenous leukemia (CML)._A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism._The second phase of mitosis, in which the chromosomes line up across the equatorial plane of the spindle prior to separation.","longName":"5508095v1.0:3111292v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"5508095","version":"1","preferredName":"Fluorescence in Situ Hybridization Philadelphia Chromosome","preferredDefinition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.:A translocation between chromosomes 9 and 22. It is the hallmark for chronic myelogenous leukemia (CML).","longName":"C17563:C28452","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fluorescence In Situ Hybridization","conceptCode":"C17563","definition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Philadelphia Chromosome","conceptCode":"C28452","definition":"A translocation between chromosomes 9 and 22. It is the hallmark for chronic myelogenous leukemia (CML).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E497361-8F97-5422-E053-F662850A13E5","latestVersionIndicator":"Yes","beginDate":"2016-10-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-07","modifiedBy":"ONEDATA","dateModified":"2016-10-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3111292","version":"1","preferredName":"Positive Finding Metaphase","preferredDefinition":"An observation confirming something, such as the presence of a disease, condition, or microorganism.:Arrangement of chromosomes in the equatorial plane of the central spindle to form the monaster.  Chromosomes separate into exactly similar halves. (NCI)","longName":"C38758:C16846","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Metaphase Process","conceptCode":"C16846","definition":"The second phase of mitosis, in which the chromosomes line up across the equatorial plane of the spindle prior to separation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"894FFBD5-AC96-5061-E040-BB89AD435F93","latestVersionIndicator":"Yes","beginDate":"2010-06-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-06-18","modifiedBy":"ONEDATA","dateModified":"2010-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E497361-8FA5-5422-E053-F662850A13E5","latestVersionIndicator":"Yes","beginDate":"2016-10-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-07","modifiedBy":"NYCHM","dateModified":"2017-02-02","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3061015","version":"1","preferredName":"Laboratory Procedure Outcome Percentage Integer::0 Decimal Place Value","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The result of an action._A fraction or ratio with 100 understood as the denominator._A number with no fractional part, including the negative and positive numbers as well as zero.::0_An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers._A numerical quantity measured or assigned or computed.","longName":"3061015v1.0","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"%","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":"0","format":"%","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3061014","version":"1","preferredName":"Laboratory Procedure Outcome Percentage Integer::0 Decimal Place Value","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.:Outcome; a phenomenon that follows and is caused by some previous phenomenon.:Percentage; a fraction or ratio with 100 understood as the denominator.:A number with no fractional part.::0:An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers.:A numerical quantity measured or assigned or computed.","longName":"C25294:C20200:C25613:C45255::0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Decimal Place","conceptCode":"C42646","definition":"An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8446A1A4-4444-2A88-E040-BB89AD43255A","latestVersionIndicator":"Yes","beginDate":"2010-04-15","endDate":null,"createdBy":"WHITES","dateCreated":"2010-04-15","modifiedBy":"ONEDATA","dateModified":"2010-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8446A1A4-4455-2A88-E040-BB89AD43255A","latestVersionIndicator":"Yes","beginDate":"2010-04-15","endDate":null,"createdBy":"WHITES","dateCreated":"2010-04-15","modifiedBy":"NYCHM","dateModified":"2010-12-02","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CMLF_DABR_FISH_ph_chr_meta_pct","type":"NMDP_FN","context":"NHLBI"},{"name":"CMLF_PHPI_FISH_ph_chr_meta_pct","type":"NMDP_FN","context":"NHLBI"},{"name":"CMLP_LSDX_FISH_ph_chr_meta_pct","type":"NMDP_FN","context":"NHLBI"},{"name":"CMLP_LSLE_FISH_ph_chr_meta_pct","type":"NMDP_FN","context":"NHLBI"},{"name":"CMLP_LTHM_FISH_ph_chr_meta_pct","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the percent value of","type":"Preferred Question Text","description":"What was the percent value of philadelphia chromosome positive metaphases found via fluorescence in situ hybridization?","url":null,"context":"NHLBI"},{"name":"% Ph+ metaphases (t(9;22)(q34;q11) and variants)","type":"Alternate Question Text","description":"% Ph+ metaphases (t(9;22)(q34;q11) and variants)","url":null,"context":"NHLBI"},{"name":"% Ph+ metaphases (t(9;22)(q34;q11) and variants)","type":"Application Standard Question Text","description":"% Ph+ metaphases (t(9;22)(q34;q11) and variants)","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E497361-8FBD-5422-E053-F662850A13E5","latestVersionIndicator":"Yes","beginDate":"2016-10-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-07","modifiedBy":"NYCHM","dateModified":"2017-02-02","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}